Should I stop taking Nustendi (generic name) and then do a blood test or continue taking the medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

You should not stop taking Nustendi before your blood test unless specifically instructed to do so by your healthcare provider. Most lipid panels and other routine blood tests are designed to monitor how your medication is working while you're taking it, so continuing your medication provides the most accurate assessment of its effectiveness. Stopping the medication before testing could lead to misleading results that don't reflect how the drug is managing your cholesterol levels during regular use. If your doctor wants to evaluate your baseline lipid levels without medication influence, they would explicitly instruct you to temporarily discontinue the medication for a specific period before testing. This is because Nustendi works by reducing cholesterol production in the liver and decreasing cholesterol absorption in the intestines, effects that would begin to diminish within days of stopping the medication, as seen in studies such as 1. Always consult with your healthcare provider about any questions regarding medication management before blood tests to ensure you receive the most appropriate guidance for your specific situation. Some key points to consider include:

  • The importance of monitoring medication effectiveness through blood tests while the patient is on the medication
  • The potential for misleading results if the medication is stopped before testing
  • The need for explicit instruction from a healthcare provider to discontinue medication before a blood test
  • The mechanism of action of Nustendi in reducing cholesterol production and absorption, as discussed in 1, which supports the continuation of the medication during blood testing for accurate assessment of its effects.

References

Research

Bempedoic Acid: A Review in Cardiovascular Risk Reduction in Statin-Intolerant Patients.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.